The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Clinical significance of tumor markers as prognostic factors in patients with metastatic gastric cancer receiving first-line chemotherapy.
J. Jo
No relevant relationships to disclose
M. Ryu
No relevant relationships to disclose
D. Koo
No relevant relationships to disclose
B. Ryoo
No relevant relationships to disclose
H. J. Kim
No relevant relationships to disclose
J. Lee
No relevant relationships to disclose
H. Chang
No relevant relationships to disclose
T. W. Kim
No relevant relationships to disclose
K. D. Choi
No relevant relationships to disclose
G. H. Lee
No relevant relationships to disclose
H. Jung
No relevant relationships to disclose
K. C. Kim
No relevant relationships to disclose
J. H. Yook
No relevant relationships to disclose
S. T. Oh
No relevant relationships to disclose
B. S. Kim
No relevant relationships to disclose
J. Kim
No relevant relationships to disclose
Y. Kang
No relevant relationships to disclose